Literature DB >> 11257263

Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor.

G J Botma1, A J Verhoeven, H Jansen.   

Abstract

The common -216G-->A and -480C-->T substitutions in the promoter region of the human hepatic lipase (LIPC) gene show high allelic association, and are correlated with decreased hepatic lipase activity and increased high-density lipoprotein cholesterol levels. To test the functionality of these substitutions, CAT-reporter assays were performed in HepG2 cells. LIPC (-650/+48) but not (-650/+61) promoter constructs showed transcriptional activity. LIPC (-650/+48) constructs with both -216A and -480T exhibited significantly lower promoter activity (-45%) than the wild-type form. Activities of -289/+48 constructs were not significantly affected by the -216G-->A substitution. The -480C/T site lies within a binding region for Upstream Stimulatory Factor (USF). Gel-shift assays showed that the binding affinity of USF protein for HL specific oligonucleotides was decreased four-fold by the -480C-->T substitution. However, promoter activity of the -650/+48 constructs was not significantly affected by the -480C-->T substitution alone. Co-transfection of HepG2 cells with USF(43) cDNA yielded a similar dose-dependent increase in activity of all -650/+48 constructs; the absolute difference in promoter activity increased but the relative difference between the variant promoter forms was maintained. Our studies demonstrate that the common LIPC promoter variation is functional, which explains the association of the -480T allele with a lower hepatic lipase activity in man.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257263     DOI: 10.1016/s0021-9150(00)00478-0

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  17 in total

1.  Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides.

Authors:  Hilary Coon; Yuanpei Xin; Paul N Hopkins; Richard M Cawthon; Sandra J Hasstedt; Steven C Hunt
Journal:  Hum Genet       Date:  2005-06-16       Impact factor: 4.132

2.  Genetic variation in the hepatic lipase gene and the risk of coronary heart disease among US diabetic men: potential interaction with obesity.

Authors:  C Zhang; R Lopez-Ridaura; E B Rimm; T Li; D J Hunter; F B Hu
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

3.  Dietary fat modulation of hepatic lipase variant -514 C/T for lipids: a crossover randomized dietary intervention trial in Caribbean Hispanics.

Authors:  C E Smith; M I Van Rompay; J Mattei; J F Garcia; B Garcia-Bailo; A H Lichtenstein; K L Tucker; J M Ordovás
Journal:  Physiol Genomics       Date:  2017-09-22       Impact factor: 3.107

4.  A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS.

Authors:  Kris Richardson; Chao-Qiang Lai; Laurence D Parnell; Yu-Chi Lee; Jose M Ordovas
Journal:  BMC Genomics       Date:  2011-10-13       Impact factor: 3.969

5.  LIPC variants in the promoter and intron 1 modify HDL-C levels in a sex-specific fashion.

Authors:  Mary F Feitosa; Richard H Myers; James S Pankow; Michael A Province; Ingrid B Borecki
Journal:  Atherosclerosis       Date:  2008-09-17       Impact factor: 5.162

6.  Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population.

Authors:  Ugur Hodoglugil; David W Williamson; Robert W Mahley
Journal:  J Lipid Res       Date:  2009-09-04       Impact factor: 5.922

7.  Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2.

Authors:  D van Deursen; H Jansen; A J M Verhoeven
Journal:  Diabetologia       Date:  2008-08-30       Impact factor: 10.122

8.  Multiple Hepatic Regulatory Variants at the GALNT2 GWAS Locus Associated with High-Density Lipoprotein Cholesterol.

Authors:  Tamara S Roman; Amanda F Marvelle; Marie P Fogarty; Swarooparani Vadlamudi; Arlene J Gonzalez; Martin L Buchkovich; Jeroen R Huyghe; Christian Fuchsberger; Anne U Jackson; Ying Wu; Mete Civelek; Aldons J Lusis; Kyle J Gaulton; Praveen Sethupathy; Antti J Kangas; Pasi Soininen; Mika Ala-Korpela; Johanna Kuusisto; Francis S Collins; Markku Laakso; Michael Boehnke; Karen L Mohlke
Journal:  Am J Hum Genet       Date:  2015-12-03       Impact factor: 11.025

9.  Functional Haplotype of LIPC Induces Triglyceride-Mediated Suppression of HDL-C Levels According to Genome-Wide Association Studies.

Authors:  Yu-Huang Liao; Leay-Kiaw Er; Semon Wu; Yu-Lin Ko; Ming-Sheng Teng
Journal:  Genes (Basel)       Date:  2021-01-22       Impact factor: 4.096

10.  The -514C/T Polymorphism of Hepatic Lipase Gene among Iranian Patients with Coronary Heart Disease.

Authors:  K Ghatreh Samani; M Noori; M Rohbani Nobar; M Hashemzadeh Chaleshtory; E Farrokhi; M Darabi Amin
Journal:  Iran J Public Health       Date:  2012-01-31       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.